BioPharma Credit gets $200 million revolving facility via JPMorgan

By Sarah Lizee

Olympia, Wash., May 26 – BioPharma Credit plc entered into a $200 million revolving credit facility with JPMorgan Chase Bank, NA, according to a press release.

The company will pay a commitment fee on undrawn amounts of 200 basis points and a Libor margin of 400 bps on drawn amounts.

There are financial covenants under the facility.

Proceeds may be used for investment and for working capital purposes.

The specialist life sciences debt investor is based in the United Kingdom.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.